Ergoteles LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$299,918
-46.9%
119,967
-10.4%
0.01%
-45.0%
Q3 2022$565,000
-38.3%
133,952
+33.6%
0.02%
-44.4%
Q4 2021$915,000
+186.8%
100,229
+235.4%
0.04%
+200.0%
Q3 2021$319,00029,8850.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders